comparemela.com

Latest Breaking News On - Inducement grant - Page 6 : comparemela.com

Vislink Technologies, Inc Announces Inducement Grant Under

Mt. Olive, NJ, July 07, 2023 (GLOBE NEWSWIRE) Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that on July 5,.

Charlotte van hertumTom coltonMatt gloverSteven teeseExchange commissionCompany nasdaqVislink technologies incGateway group incWhile the companyVice presidentNasdaq listing rulePrivate securities litigation reform actAnnual reportVislink technologiesMobile viewpointNasdaq capital market

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today.

Jonathanb zungCompany fourthRoche groupDrug administrationCuris incPrnewswire curis incChief development officerInducement grantFourth amendedIncentive planAim lymphomaAim leukemiaOrphan drug designationTakeaim leukemiaHealth care amp hospitalsMedical pharmaceuticals

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTodd jamesviridian therapeutics inc senior viceCompany or viridianViridian therapeutics incCorporate affairsWall streetCompensation committeeInducement grantIncentive planNasdaq listing ruleMedia contactJamesviridian therapeuticsInc senior vice presidentViridian therapeutics

Curis Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today.

Prnewswire curis incCompany fourthCompensation committeeInducement grantSuch inducement grantFourth amendedIncentive plan

Curis Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Curis Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Prnewswire curis incCompany fourthRoche groupDrug administrationCuris incCompensation committeeInducement grantSuch inducement grantFourth amendedIncentive planAim lymphomaAim leukemiaOrphan drug designationTakeaim leukemiaTakeaim lymphoma

vimarsana © 2020. All Rights Reserved.